Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Chongqing Pharscin Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥833.94K ≈ $122.03K USD) by net assets (CN¥1.71 Billion ≈ $250.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)

Cash flow conversion efficiency of Chongqing Pharscin Pharmaceutical Co Ltd from 2013 to 2024. This chart illustrates how Chongqing Pharscin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Chongqing Pharscin Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Chongqing Pharscin Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Chongqing Pharscin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chongqing Pharscin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Chongqing Pharscin Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Yangmei Chemical Co Ltd SHG:600691	-0.013x
Ningxia Building Materials Group Co Ltd SHG:600449	0.044x
Guangzhou Hengyun Enterprises Holding Ltd SHE:000531	0.058x
Solstad Offsho OL:SOFF	0.234x
Archicom S.A. WAR:ARH	0.087x
Shenzhen JT Automation Equipment Co Ltd SHE:300400	0.060x
Banco Patagonia BA:BPAT	-0.006x
Forward Industries Inc NASDAQ:FORD	-0.002x

Annual Cash Flow Conversion Efficiency for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Chongqing Pharscin Pharmaceutical Co Ltd from 2013 to 2024. Review Chongqing Pharscin Pharmaceutical Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.66 Billion ≈ $242.91 Million	CN¥161.77 Million ≈ $23.67 Million	0.097x	-28.12%
2023-12-31	CN¥1.62 Billion ≈ $236.75 Million	CN¥219.34 Million ≈ $32.10 Million	0.136x	+1573.59%
2022-12-31	CN¥1.61 Billion ≈ $235.65 Million	CN¥13.04 Million ≈ $1.91 Million	0.008x	-87.62%
2021-12-31	CN¥1.27 Billion ≈ $185.24 Million	CN¥82.85 Million ≈ $12.12 Million	0.065x	-31.94%
2020-12-31	CN¥1.18 Billion ≈ $172.94 Million	CN¥113.64 Million ≈ $16.63 Million	0.096x	+56.20%
2019-12-31	CN¥1.07 Billion ≈ $156.69 Million	CN¥65.92 Million ≈ $9.65 Million	0.062x	+60.48%
2018-12-31	CN¥828.91 Million ≈ $121.30 Million	CN¥31.80 Million ≈ $4.65 Million	0.038x	-66.05%
2017-12-31	CN¥719.95 Million ≈ $105.35 Million	CN¥81.34 Million ≈ $11.90 Million	0.113x	-9.70%
2016-12-31	CN¥461.42 Million ≈ $67.52 Million	CN¥57.73 Million ≈ $8.45 Million	0.125x	-30.78%
2015-12-31	CN¥365.71 Million ≈ $53.51 Million	CN¥66.10 Million ≈ $9.67 Million	0.181x	+167.95%
2014-12-31	CN¥299.77 Million ≈ $43.87 Million	CN¥20.22 Million ≈ $2.96 Million	0.067x	-65.66%
2013-12-31	CN¥240.97 Million ≈ $35.26 Million	CN¥47.34 Million ≈ $6.93 Million	0.196x	--

About Chongqing Pharscin Pharmaceutical Co Ltd

SHE:002907 China Drug Manufacturers - Specialty & Generic

Market Cap

$788.90 Million

CN¥5.39 Billion CNY

Market Cap Rank

#9581 Global

#2375 in China

Share Price

CN¥12.91

Change (1 day)

-2.86%

52-Week Range

CN¥11.69 - CN¥17.34

All Time High

CN¥42.89